According to Novo Nordisks published trial data, the most commonly reported side effects include: Nausea : Reported in up to 20% of patients, particularly during the dose-escalation phase
Resep resmi: Untuk obat resep, resep obat online diberikan oleh dokter berlisensi (memiliki legalitas resmi atau STR dan SIP) setelah sesi konsultasi
This common concern affects many patients starting glucagon-like peptide-1 (GLP-1) receptor agonists like semaglutide (Ozempic, Wegovy), liraglutide (Victoza, Saxenda), or dulaglutide (Trulicity) for type 2 diabetes or weight management
Depending on the individual and the particular prescription they are taking, the answer to this question may differ
Women with polycystic ovary syndrome (PCOS) are particularly often affected
Regulation of abdominal adiposity by probiotics ( Lactobacillus gasseri SBT2055) in adults with obese tendencies in a randomized controlled trial